$MAS
MASCO CORP /DE/

2022 Q1 Form 10-Q Financial Statement

#000006299622000018 Filed on April 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $2.201B $1.970B
YoY Change 11.73% 24.6%
Cost Of Revenue $1.497B $1.270B
YoY Change 17.87% 22.82%
Gross Profit $704.0M $700.0M
YoY Change 0.57% 27.97%
Gross Profit Margin 31.99% 35.53%
Selling, General & Admin $351.0M $335.0M
YoY Change 4.78% 4.04%
% of Gross Profit 49.86% 47.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.00M $43.00M
YoY Change -18.6% 30.3%
% of Gross Profit 4.97% 6.14%
Operating Expenses $351.0M $335.0M
YoY Change 4.78% 4.04%
Operating Profit $353.0M $365.0M
YoY Change -3.29% 62.22%
Interest Expense $25.00M $202.0M
YoY Change -87.62% 477.14%
% of Operating Profit 7.08% 55.34%
Other Income/Expense, Net -$26.00M -$208.0M
YoY Change -87.5% 307.84%
Pretax Income $327.0M $157.0M
YoY Change 108.28% -9.77%
Income Tax $75.00M $43.00M
% Of Pretax Income 22.94% 27.39%
Net Earnings $233.0M $94.00M
YoY Change 147.87% -82.26%
Net Earnings / Revenue 10.59% 4.77%
Basic Earnings Per Share $0.98 $0.34
Diluted Earnings Per Share $0.97 $0.34
COMMON SHARES
Basic Shares Outstanding 239.0M shares 256.0M shares
Diluted Shares Outstanding 241.0M shares 257.0M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $479.0M $838.0M
YoY Change -42.84% 9.26%
Cash & Equivalents $479.0M $838.0M
Short-Term Investments
Other Short-Term Assets $107.0M $115.0M
YoY Change -6.96% 43.75%
Inventory $1.340B $948.0M
Prepaid Expenses
Receivables $1.502B $1.305B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.428B $3.206B
YoY Change 6.92% 16.79%
LONG-TERM ASSETS
Property, Plant & Equipment $892.0M $894.0M
YoY Change -0.22% 3.83%
Goodwill $565.0M $588.0M
YoY Change -3.91% 13.51%
Intangibles $379.0M $378.0M
YoY Change 0.26% 43.18%
Long-Term Investments
YoY Change
Other Assets $109.0M $326.0M
YoY Change -66.56% 16.01%
Total Long-Term Assets $2.140B $2.368B
YoY Change -9.63% 13.03%
TOTAL ASSETS
Total Short-Term Assets $3.428B $3.206B
Total Long-Term Assets $2.140B $2.368B
Total Assets $5.568B $5.574B
YoY Change -0.11% 15.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.114B $925.0M
YoY Change 20.43% 24.5%
Accrued Expenses $749.0M $803.0M
YoY Change -6.72% 6.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $273.0M $6.000M
YoY Change 4450.0% 20.0%
Total Short-Term Liabilities $2.136B $1.748B
YoY Change 22.2% 16.22%
LONG-TERM LIABILITIES
Long-Term Debt $2.946B $2.955B
YoY Change -0.3% 6.64%
Other Long-Term Liabilities $407.0M $458.0M
YoY Change -11.14% -20.07%
Total Long-Term Liabilities $3.353B $3.413B
YoY Change -1.76% 2.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.136B $1.748B
Total Long-Term Liabilities $3.353B $3.413B
Total Liabilities $5.668B $5.332B
YoY Change 6.3% 6.53%
SHAREHOLDERS EQUITY
Retained Earnings -$833.0M -$116.0M
YoY Change 618.1% -71.84%
Common Stock $236.0M $253.0M
YoY Change -6.72% -3.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$371.0M -$17.00M
YoY Change
Total Liabilities & Shareholders Equity $5.568B $5.574B
YoY Change -0.11% 15.17%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $233.0M $94.00M
YoY Change 147.87% -82.26%
Depreciation, Depletion And Amortization $35.00M $43.00M
YoY Change -18.6% 30.3%
Cash From Operating Activities -$227.0M -$89.00M
YoY Change 155.06% -3.26%
INVESTING ACTIVITIES
Capital Expenditures -$27.00M -$30.00M
YoY Change -10.0% 25.0%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $1.000M -$4.000M
YoY Change -125.0% 300.0%
Cash From Investing Activities -$26.00M -$25.00M
YoY Change 4.0% -103.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $363.0M $303.0M
YoY Change 19.8% -47.94%
Debt Paid & Issued, Net $3.000M
YoY Change
Cash From Financing Activities -$187.0M -$359.0M
YoY Change -47.91% -43.82%
NET CHANGE
Cash From Operating Activities -$227.0M -$89.00M
Cash From Investing Activities -$26.00M -$25.00M
Cash From Financing Activities -$187.0M -$359.0M
Net Change In Cash -$447.0M -$486.0M
YoY Change -8.02% -794.29%
FREE CASH FLOW
Cash From Operating Activities -$227.0M -$89.00M
Capital Expenditures -$27.00M -$30.00M
Free Cash Flow -$200.0M -$59.00M
YoY Change 238.98% -13.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000062996
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Trading Symbol
TradingSymbol
MAS
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
235940440 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
926000000 USD
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1502000000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1171000000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
107000000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
109000000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
809000000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
702000000 USD
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-5794
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Masco Corporation
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-1794485
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
17450 College Parkway,
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Livonia,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MI
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
48152
CY2022Q1 dei City Area Code
CityAreaCode
313
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
274-7400
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $1.00 par value
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
409000000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
383000000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
122000000 USD
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
131000000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1340000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1216000000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3428000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3422000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
892000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
896000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
565000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
568000000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
379000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
388000000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
195000000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
187000000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
226000000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
109000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
114000000 USD
CY2022Q1 us-gaap Assets
Assets
5568000000 USD
CY2021Q4 us-gaap Assets
Assets
5575000000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1114000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1045000000 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
273000000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
10000000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
749000000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
884000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2136000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1939000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2946000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2949000000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
179000000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172000000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
407000000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
437000000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
5668000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
5497000000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Redemption Value
RedeemableNoncontrollingInterestEquityRedemptionValue
21000000 USD
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Redemption Value
RedeemableNoncontrollingInterestEquityRedemptionValue
22000000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
235600000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
235600000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241200000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241200000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
236000000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
241000000 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-833000000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-652000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
232000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-371000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-179000000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
250000000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
235000000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-121000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
56000000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5568000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5575000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2201000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1970000000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1497000000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1270000000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
704000000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
700000000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
351000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
335000000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
353000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
365000000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
25000000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
202000000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26000000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-208000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
327000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
252000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
114000000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
20000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
233000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
94000000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2022Q1 us-gaap Profit Loss
ProfitLoss
252000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
114000000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
20000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
233000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
94000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1481000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-5000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-4000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-12000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
242000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
90000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
15000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
227000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82000000 USD
CY2022Q1 mas Cash Provided By Used In Operating Activities Before Reconciling Adjustments
CashProvidedByUsedInOperatingActivitiesBeforeReconcilingAdjustments
334000000 USD
CY2021Q1 mas Cash Provided By Used In Operating Activities Before Reconciling Adjustments
CashProvidedByUsedInOperatingActivitiesBeforeReconcilingAdjustments
323000000 USD
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
349000000 USD
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
195000000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
127000000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
78000000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-85000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-139000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-227000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89000000 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1326000000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
364000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
303000000 USD
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
263000000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
67000000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
36000000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2021Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
160000000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17000000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14000000 USD
CY2022Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-3000000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-1000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-187000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-359000000 USD
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
27000000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
30000000 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2000000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
1000000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-447000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-486000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
926000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1326000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
840000000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
421000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
90000000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
303000000 USD
CY2021Q1 mas Surrendered Non Cash
SurrenderedNonCash
13000000 USD
CY2021Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-6000000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
217000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
56000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
242000000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
364000000 USD
CY2022Q1 mas Surrendered Non Cash
SurrenderedNonCash
17000000 USD
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
67000000 USD
CY2022Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
1000000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-121000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2201000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1970000000 USD
CY2022Q1 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
2000000 USD
CY2021Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
1000000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28000000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
67000000 USD
CY2022Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
5000000 USD
CY2021Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6000000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7000000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
2000000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1000000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2000000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1000000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1000000 USD
CY2022Q1 mas Financing Receivable Allowance For Credit Losses Assets Held For Sale
FinancingReceivableAllowanceForCreditLossesAssetsHeldForSale
0 USD
CY2021 mas Financing Receivable Allowance For Credit Losses Assets Held For Sale
FinancingReceivableAllowanceForCreditLossesAssetsHeldForSale
1000000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
270000000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8000000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6000000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43000000 USD
CY2022Q1 us-gaap Goodwill Gross
GoodwillGross
986000000 USD
CY2022Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
421000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
565000000 USD
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
989000000 USD
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
421000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
568000000 USD
CY2022Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-3000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
565000000 USD
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
109000000 USD
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
109000000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
83000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
279000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
75000000 USD
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
80000000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
83000000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9000000 USD
CY2021 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
38000000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1000000 USD
CY2021 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-8000000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8000000 USD
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
31000000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
0 USD
CY2021 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-2000000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
82000000 USD
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
80000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1495000000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-168000000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
337790 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
59
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
353000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
365000000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26000000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-208000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
327000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157000000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4000000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4000000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2022Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
2000000 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2022Q1 mas Pensionand Other Postretirement Benefit Expense Excluding Current Service Cost
PensionandOtherPostretirementBenefitExpenseExcludingCurrentServiceCost
2000000 USD
CY2021Q1 mas Pensionand Other Postretirement Benefit Expense Excluding Current Service Cost
PensionandOtherPostretirementBenefitExpenseExcludingCurrentServiceCost
11000000 USD
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 USD
CY2021Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
3000000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000 USD
CY2022Q1 mas Other Nonoperating Income Expense Other Income Expense Items Net
OtherNonoperatingIncomeExpenseOtherIncomeExpenseItemsNet
-1000000 USD
CY2021Q1 mas Other Nonoperating Income Expense Other Income Expense Items Net
OtherNonoperatingIncomeExpenseOtherIncomeExpenseItemsNet
0 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
233000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
94000000 USD
CY2022Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
1000000 USD
CY2021Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-6000000 USD
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
234000000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
88000000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256000000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
241000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257000000 shares
CY2021Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2000000000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6100000 shares
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
364000000 USD
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
764000000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.280
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.280
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.140
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
CY2021Q1 mas Income Tax Expense Elimination Of Disproportionate Tax Effect From Accumulated Other Comprehensive Loss
IncomeTaxExpenseEliminationOfDisproportionateTaxEffectFromAccumulatedOtherComprehensiveLoss
5000000 USD
CY2021Q1 mas Income Tax Expense Anticipated Loss On Termination Of Qualified Domestic Defined Benefit Pension Plans
IncomeTaxExpenseAnticipatedLossOnTerminationOfQualifiedDomesticDefinedBenefitPensionPlans
5000000 USD

Files In Submission

Name View Source Status
0000062996-22-000018-index-headers.html Edgar Link pending
0000062996-22-000018-index.html Edgar Link pending
0000062996-22-000018.txt Edgar Link pending
0000062996-22-000018-xbrl.zip Edgar Link pending
exhibit10a.htm Edgar Link pending
exhibit10a001.jpg Edgar Link pending
exhibit10a002.jpg Edgar Link pending
exhibit10a003.jpg Edgar Link pending
exhibit10a004.jpg Edgar Link pending
exhibit10a005.jpg Edgar Link pending
exhibit10a006.jpg Edgar Link pending
exhibit10a007.jpg Edgar Link pending
exhibit10a008.jpg Edgar Link pending
exhibit10a009.jpg Edgar Link pending
exhibit10a010.jpg Edgar Link pending
exhibit10a011.jpg Edgar Link pending
exhibit10a012.jpg Edgar Link pending
exhibit10a013.jpg Edgar Link pending
exhibit10a014.jpg Edgar Link pending
exhibit10a015.jpg Edgar Link pending
exhibit10a016.jpg Edgar Link pending
exhibit10a017.jpg Edgar Link pending
exhibit10a018.jpg Edgar Link pending
exhibit10a019.jpg Edgar Link pending
exhibit10a020.jpg Edgar Link pending
exhibit10a021.jpg Edgar Link pending
exhibit10a022.jpg Edgar Link pending
exhibit10a023.jpg Edgar Link pending
exhibit10a024.jpg Edgar Link pending
exhibit10a025.jpg Edgar Link pending
exhibit10a026.jpg Edgar Link pending
exhibit10a027.jpg Edgar Link pending
exhibit10a028.jpg Edgar Link pending
exhibit10a029.jpg Edgar Link pending
exhibit10a030.jpg Edgar Link pending
exhibit10a031.jpg Edgar Link pending
exhibit10a032.jpg Edgar Link pending
exhibit10a033.jpg Edgar Link pending
exhibit10a034.jpg Edgar Link pending
exhibit10a035.jpg Edgar Link pending
exhibit10a036.jpg Edgar Link pending
exhibit10a037.jpg Edgar Link pending
exhibit10a038.jpg Edgar Link pending
exhibit10a039.jpg Edgar Link pending
exhibit10a040.jpg Edgar Link pending
exhibit10a041.jpg Edgar Link pending
exhibit10a042.jpg Edgar Link pending
exhibit10a043.jpg Edgar Link pending
exhibit10a044.jpg Edgar Link pending
exhibit10a045.jpg Edgar Link pending
exhibit10a046.jpg Edgar Link pending
exhibit10a047.jpg Edgar Link pending
exhibit10a048.jpg Edgar Link pending
exhibit10a049.jpg Edgar Link pending
exhibit10a050.jpg Edgar Link pending
exhibit10a051.jpg Edgar Link pending
exhibit10a052.jpg Edgar Link pending
exhibit10a053.jpg Edgar Link pending
exhibit10a054.jpg Edgar Link pending
exhibit10a055.jpg Edgar Link pending
exhibit10a056.jpg Edgar Link pending
exhibit10a057.jpg Edgar Link pending
exhibit10a058.jpg Edgar Link pending
exhibit10a059.jpg Edgar Link pending
exhibit10a060.jpg Edgar Link pending
exhibit10a061.jpg Edgar Link pending
exhibit10a062.jpg Edgar Link pending
exhibit10a063.jpg Edgar Link pending
exhibit10a064.jpg Edgar Link pending
exhibit10a065.jpg Edgar Link pending
exhibit10a066.jpg Edgar Link pending
exhibit10a067.jpg Edgar Link pending
exhibit10a068.jpg Edgar Link pending
exhibit10a069.jpg Edgar Link pending
exhibit10a070.jpg Edgar Link pending
exhibit10a071.jpg Edgar Link pending
exhibit10a072.jpg Edgar Link pending
exhibit10a073.jpg Edgar Link pending
exhibit10a074.jpg Edgar Link pending
exhibit10a075.jpg Edgar Link pending
exhibit10a076.jpg Edgar Link pending
exhibit10a077.jpg Edgar Link pending
exhibit10a078.jpg Edgar Link pending
exhibit10a079.jpg Edgar Link pending
exhibit10a080.jpg Edgar Link pending
exhibit10a081.jpg Edgar Link pending
exhibit10a082.jpg Edgar Link pending
exhibit10a083.jpg Edgar Link pending
exhibit10a084.jpg Edgar Link pending
exhibit10a085.jpg Edgar Link pending
exhibit10a086.jpg Edgar Link pending
exhibit10a087.jpg Edgar Link pending
exhibit10a088.jpg Edgar Link pending
exhibit10a089.jpg Edgar Link pending
exhibit10a090.jpg Edgar Link pending
exhibit10a091.jpg Edgar Link pending
exhibit10a092.jpg Edgar Link pending
exhibit10a093.jpg Edgar Link pending
exhibit10a094.jpg Edgar Link pending
exhibit10a095.jpg Edgar Link pending
exhibit10a096.jpg Edgar Link pending
exhibit10a097.jpg Edgar Link pending
exhibit10a098.jpg Edgar Link pending
exhibit10a099.jpg Edgar Link pending
exhibit10a100.jpg Edgar Link pending
exhibit10a101.jpg Edgar Link pending
exhibit10a102.jpg Edgar Link pending
exhibit10a103.jpg Edgar Link pending
exhibit10a104.jpg Edgar Link pending
exhibit10a105.jpg Edgar Link pending
exhibit10a106.jpg Edgar Link pending
exhibit10a107.jpg Edgar Link pending
exhibit10a108.jpg Edgar Link pending
exhibit10a109.jpg Edgar Link pending
exhibit10a110.jpg Edgar Link pending
exhibit10a111.jpg Edgar Link pending
exhibit10a112.jpg Edgar Link pending
exhibit10a113.jpg Edgar Link pending
exhibit10a114.jpg Edgar Link pending
exhibit10a115.jpg Edgar Link pending
exhibit10a116.jpg Edgar Link pending
exhibit10a117.jpg Edgar Link pending
exhibit10a118.jpg Edgar Link pending
exhibit10a119.jpg Edgar Link pending
exhibit10a120.jpg Edgar Link pending
exhibit10a121.jpg Edgar Link pending
exhibit10a122.jpg Edgar Link pending
exhibit10a123.jpg Edgar Link pending
exhibit10a124.jpg Edgar Link pending
exhibit10a125.jpg Edgar Link pending
exhibit10a126.jpg Edgar Link pending
exhibit10a127.jpg Edgar Link pending
exhibit10a128.jpg Edgar Link pending
exhibit10a129.jpg Edgar Link pending
exhibit10a130.jpg Edgar Link pending
exhibit10a131.jpg Edgar Link pending
exhibit10a132.jpg Edgar Link pending
exhibit10a133.jpg Edgar Link pending
exhibit10a134.jpg Edgar Link pending
exhibit10a135.jpg Edgar Link pending
exhibit10a136.jpg Edgar Link pending
exhibit10a137.jpg Edgar Link pending
exhibit10a138.jpg Edgar Link pending
exhibit10a139.jpg Edgar Link pending
exhibit10a140.jpg Edgar Link pending
exhibit10a141.jpg Edgar Link pending
exhibit10a142.jpg Edgar Link pending
exhibit10a143.jpg Edgar Link pending
exhibit10a144.jpg Edgar Link pending
exhibit10a145.jpg Edgar Link pending
exhibit10a146.jpg Edgar Link pending
exhibit10a147.jpg Edgar Link pending
exhibit10a148.jpg Edgar Link pending
exhibit10a149.jpg Edgar Link pending
exhibit10a150.jpg Edgar Link pending
exhibit10a151.jpg Edgar Link pending
exhibit10a152.jpg Edgar Link pending
exhibit10a153.jpg Edgar Link pending
exhibit10a154.jpg Edgar Link pending
exhibit10b.htm Edgar Link pending
exhibit10b001.jpg Edgar Link pending
exhibit10b002.jpg Edgar Link pending
exhibit10b003.jpg Edgar Link pending
exhibit10b004.jpg Edgar Link pending
exhibit10b005.jpg Edgar Link pending
exhibit10b006.jpg Edgar Link pending
exhibit10b007.jpg Edgar Link pending
exhibit10b008.jpg Edgar Link pending
exhibit10b009.jpg Edgar Link pending
exhibit10b010.jpg Edgar Link pending
exhibit10b011.jpg Edgar Link pending
exhibit10b012.jpg Edgar Link pending
exhibit10b013.jpg Edgar Link pending
exhibit10b014.jpg Edgar Link pending
exhibit10b015.jpg Edgar Link pending
exhibit10b016.jpg Edgar Link pending
exhibit10b017.jpg Edgar Link pending
exhibit10b018.jpg Edgar Link pending
exhibit10b019.jpg Edgar Link pending
exhibit10b020.jpg Edgar Link pending
exhibit10b021.jpg Edgar Link pending
exhibit10b022.jpg Edgar Link pending
exhibit10b023.jpg Edgar Link pending
exhibit10b024.jpg Edgar Link pending
exhibit10b025.jpg Edgar Link pending
exhibit10b026.jpg Edgar Link pending
exhibit10b027.jpg Edgar Link pending
exhibit10b028.jpg Edgar Link pending
exhibit10b029.jpg Edgar Link pending
exhibit10b030.jpg Edgar Link pending
exhibit10b031.jpg Edgar Link pending
exhibit10b032.jpg Edgar Link pending
exhibit10b033.jpg Edgar Link pending
exhibit10b034.jpg Edgar Link pending
exhibit10b035.jpg Edgar Link pending
exhibit10b036.jpg Edgar Link pending
exhibit10b037.jpg Edgar Link pending
exhibit10b038.jpg Edgar Link pending
exhibit10b039.jpg Edgar Link pending
exhibit10b040.jpg Edgar Link pending
exhibit10b041.jpg Edgar Link pending
exhibit10b042.jpg Edgar Link pending
exhibit10b043.jpg Edgar Link pending
exhibit10b044.jpg Edgar Link pending
exhibit10b045.jpg Edgar Link pending
exhibit10b046.jpg Edgar Link pending
exhibit10b047.jpg Edgar Link pending
exhibit10b048.jpg Edgar Link pending
exhibit10b049.jpg Edgar Link pending
exhibit10b050.jpg Edgar Link pending
exhibit10b051.jpg Edgar Link pending
exhibit10b052.jpg Edgar Link pending
exhibit10b053.jpg Edgar Link pending
exhibit10b054.jpg Edgar Link pending
exhibit10b055.jpg Edgar Link pending
exhibit10b056.jpg Edgar Link pending
exhibit10b057.jpg Edgar Link pending
exhibit10b058.jpg Edgar Link pending
exhibit10b059.jpg Edgar Link pending
exhibit10b060.jpg Edgar Link pending
exhibit10b061.jpg Edgar Link pending
exhibit10b062.jpg Edgar Link pending
exhibit10b063.jpg Edgar Link pending
exhibit10b064.jpg Edgar Link pending
exhibit10b065.jpg Edgar Link pending
exhibit10b066.jpg Edgar Link pending
exhibit10b067.jpg Edgar Link pending
exhibit10b068.jpg Edgar Link pending
exhibit10b069.jpg Edgar Link pending
exhibit10b070.jpg Edgar Link pending
exhibit10b071.jpg Edgar Link pending
exhibit10b072.jpg Edgar Link pending
exhibit10b073.jpg Edgar Link pending
exhibit10b074.jpg Edgar Link pending
exhibit10b075.jpg Edgar Link pending
exhibit10b076.jpg Edgar Link pending
exhibit10b077.jpg Edgar Link pending
exhibit10b078.jpg Edgar Link pending
exhibit10b079.jpg Edgar Link pending
exhibit10b080.jpg Edgar Link pending
exhibit10b081.jpg Edgar Link pending
exhibit10b082.jpg Edgar Link pending
exhibit10b083.jpg Edgar Link pending
exhibit10b084.jpg Edgar Link pending
exhibit10b085.jpg Edgar Link pending
exhibit10b086.jpg Edgar Link pending
exhibit10b087.jpg Edgar Link pending
exhibit10b088.jpg Edgar Link pending
exhibit10b089.jpg Edgar Link pending
exhibit10b090.jpg Edgar Link pending
exhibit10b091.jpg Edgar Link pending
exhibit10b092.jpg Edgar Link pending
exhibit10b093.jpg Edgar Link pending
exhibit10b094.jpg Edgar Link pending
exhibit10b095.jpg Edgar Link pending
exhibit10b096.jpg Edgar Link pending
exhibit31a03312022.htm Edgar Link pending
exhibit31b03312022.htm Edgar Link pending
exhibit3203312022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mas-20220331.htm Edgar Link pending
mas-20220331.xsd Edgar Link pending
mas-20220331_cal.xml Edgar Link unprocessable
mas-20220331_def.xml Edgar Link unprocessable
mas-20220331_htm.xml Edgar Link completed
mas-20220331_lab.xml Edgar Link unprocessable
mas-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending